Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
In 2015, the EHRA Scientifc Initiatives Committee (SIC) launched two new initiatives : Snapshot Surveys and Patient Surveys.
The Snap Shot Survey is used to map the daily Cardiac Electrophysiology (EP) practice in Europe, but unlike online EP Wire Surveys, the Snap Shot Surveys are based on individual studies and at an individual level.It is a limited survey (25 questions max) including consecutive patients for 2-8 weeks.
The SIC launched a new snapshot survey in April 2017, over a period of 2 months in the 6 following countries : France, Germany, Italy, Poland, Netherlands and UK.
The topic tackled was 'Subcutaneous Implantable Cardioverter Defibrillator Implantation'.
The aim of this European Heart Rhythm Association (EHRA) prospective snapshot survey was to provide better insight into ICD utilization across a broad range of European tertiary centres, and to try to identify some important factors that could direct the choice towards the use of an S-ICD or a TV-ICD in a particular patient.
It is a questionnaire available on Internet dedicated to the patients.
The link to the questionnaire is handed out to the patients (ambulatory or hospitalised) by nurses or doctors to be completed anonymously.
The SIC undertook a patient survey in November 2016, over a period of 2 months in the following countries : Denmark, France, Italy, Norway, Poland, Romania, Spain and Sweden.
This patient survey was carried out among patients with implantable electronic devices. The main purpose of this survey was to describe in detail the knowledge, values and preferences of patients with an implantable device across Europe. By identifying the education, compliance, experience and concerns of patients in daily clinical practice in Europe, this survey was expected to highlight the gaps between current recommendations and clinical practice and the areas of uncertainties.
The first Patient Survey about Education & Compliance of Patients taking Anticoagulants was dedicated to Patients who have or have had Atrial Fibrillation. It was conducted for 3 months in 8 different countries and languages.
Take a look at the 2 manuscripts that were published in the EP Europace Journal following the survey.
Our Mission: To Reduce the Burden of Cardiovascular Disease
© 2019 European Society of Cardiology. All rights reserved